StockData

China SXT Pharmaceuticals, Inc. (SXTC) income statement

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$2.83−0.03 (-1.05%)

Close on Nov 18, 2026Market cap $2.71MP/E –Yield –

China SXT Pharmaceuticals, Inc. income statement

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY2026

Gross margin
21.9%
Operating margin
-625.9%
Net margin
-545.2%
Return on equity, FY2026
-27.5%

Financial strength

Current ratio
7.93
Debt to equity
0.03
Debt to assets
2.9%
Cash to current liabilities
647.8%

Valuation

P/E ratio
–
Price to sales
2.38
Price to book
0.09
Dividend yield
–

See a number that looks wrong?